These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37042152)

  • 41. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
    Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
    [No Abstract]   [Full Text] [Related]  

  • 42. Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features.
    Lucas E; Carrick KS
    Semin Diagn Pathol; 2022 May; 39(3):159-175. PubMed ID: 35397943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
    Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
    Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
    Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
    Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
    Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
    Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequent CTNNB1 or PIK3CA Mutations Occurred in Endometrial Endometrioid Adenocarcinoma With High Levels of Microsatellite Instability and Loss of MSH2/MSH6 Expression.
    Huang HN; Kuo CW; Lin MC; Mao TL; Kuo KT
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):284-289. PubMed ID: 30789355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endometrioid carcinoma of the endometrium with sertoliform differentiation.
    Usadi RS; Bentley RC
    Int J Gynecol Pathol; 1995 Oct; 14(4):360-4. PubMed ID: 8598340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ciliated Carcinoma of the Endometrium.
    Guerrieri C; Anderson P; Hudacko R
    Int J Gynecol Pathol; 2021 Mar; 40(2):141-147. PubMed ID: 32897959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects.
    Clement PB; Young RH
    Adv Anat Pathol; 2002 May; 9(3):145-84. PubMed ID: 11981113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endometrioid Endometrial Carcinoma With Spindle Cells-Aberrant p16 and p53 Expression.
    Sonawane S; Elfituri O; Zhang Y; Yordan E; Ree N
    Int J Surg Pathol; 2019 Apr; 27(2):203-207. PubMed ID: 29953305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability.
    Bossuyt V; Buza N; Ngo NT; Much MA; Asis MC; Schwartz PE; Hui P
    Mod Pathol; 2013 Sep; 26(9):1264-9. PubMed ID: 23558568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
    Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
    Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case.
    Sasaki T; Sugiyama T; Nanjo H; Hoshi N; Murakami M; Sugita A; Takahashi M; Kawamura K; Ono I; Masuda H
    Pathol Int; 2001 Apr; 51(4):308-13. PubMed ID: 11350616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coexistent Dedifferentiated Endometrioid Carcinoma of the Uterus and Adenocarcinoma of the Bladder in Lynch Syndrome: Case Report and Review of the Literature.
    Groth JV; Prabhu S; Periakaruppan R; Ohlander S; Emmadi R; Kothari R
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):e26-e30. PubMed ID: 32167968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
    Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polypoid nodular histiocytic hyperplasia associated with endometrioid adenocarcinoma of the endometrium: report of a case.
    Akhter S; Lawrence WD; Quddus MR
    Diagn Pathol; 2014 May; 9():93. PubMed ID: 24885845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.